161 related articles for article (PubMed ID: 32268246)
1. Generation of a TLR7 heterozygous knockout line (WAe009-A-18) from human embryonic stem cells using CRISPR/Cas9.
Seo HH; Han HW; Kim JH
Stem Cell Res; 2020 May; 45():101735. PubMed ID: 32268246
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a human TLR4 compound heterozygous knockout hESC line (WAe009-A-N) to model toll-like receptor 4 deficiency by CRISPR/Cas9 system.
Ruan Y; Tian X; Li X; Zhang Y
Stem Cell Res; 2023 Dec; 73():103225. PubMed ID: 37931537
[TBL] [Abstract][Full Text] [Related]
3. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
Han HJ; Seo HH; Han HW; Kim JH
Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
[TBL] [Abstract][Full Text] [Related]
4. Generation of a TRPM8 knockout hESC line (WAe009-A-A) derived from H9 using CRISPR/Cas9.
Bai J; Zhang J; Fu W; Li S; Tian X; Li X; Zhao X; Dong J
Stem Cell Res; 2023 Mar; 67():103040. PubMed ID: 36796252
[TBL] [Abstract][Full Text] [Related]
5. Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system.
Wu F; Li X; Bai R; Li Y; Gao J; Lan F
Stem Cell Res; 2020 Oct; 48():101930. PubMed ID: 32777767
[TBL] [Abstract][Full Text] [Related]
6. Generating dHAND homozygous knockout human embryonic stem cell line (WAe009-A-59) by episomal vector-based CRISPR/Cas9 system.
Wang W; Bai R; Song X
Stem Cell Res; 2021 Aug; 55():102471. PubMed ID: 34332328
[TBL] [Abstract][Full Text] [Related]
7. Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9.
Sun W; Li X; Dong J; Zhou Y
Stem Cell Res; 2024 Feb; 74():103284. PubMed ID: 38118206
[TBL] [Abstract][Full Text] [Related]
8. Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9.
Lu F; Gao Y; Li E
Stem Cell Res; 2023 Sep; 71():103162. PubMed ID: 37429070
[TBL] [Abstract][Full Text] [Related]
9. A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.
Qin Z; Sun L; Sun X; Su H; Gao X
Stem Cell Res; 2021 Oct; 56():102562. PubMed ID: 34634758
[TBL] [Abstract][Full Text] [Related]
10. Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing.
Getachew A; Yang Z; Huang X; Wu F; Liu YY; Yan C; Yang F; Li Y
Stem Cell Res; 2021 Jul; 54():102401. PubMed ID: 34058685
[TBL] [Abstract][Full Text] [Related]
11. The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system.
Dong T; Zhang S; Chang Y; Bai R; Jiang Y; Ma S; Li Y; Jiang HF; Lu WJ
Stem Cell Res; 2021 Mar; 51():102196. PubMed ID: 33524674
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 mediated establishment of a human CSRP3 compound heterozygous knockout hESC line to model cardiomyopathy and heart failure.
Sun L; Li J; Li E; Niu S; Qin Z; Zhi Q; Zhao J; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Dec; 49():102077. PubMed ID: 33176267
[TBL] [Abstract][Full Text] [Related]
13. Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system.
Wu X; Wang X
Stem Cell Res; 2023 Jun; 69():103082. PubMed ID: 36963213
[TBL] [Abstract][Full Text] [Related]
14. Generation of NERCe003-A-3, a p53 compound heterozygous mutation human embryonic stem cell line, by CRISPR/Cas9 editing.
Li Y; Huang C; Zha L; Kong M; Yang Q; Zhu Y; Peng Y; Ouyang Q; Lu G; Lin G; Zhou D
Stem Cell Res; 2019 Jan; 34():101371. PubMed ID: 30658254
[TBL] [Abstract][Full Text] [Related]
15. Generation of a COL4A5 heterozygous mutation human embryonic stem cell line (WAe009-A-58) using an episomal vector-based CRISPR/Cas9 system.
Tian L; Wu F; Bai R; Ma S; Zheng H; Liu WJ; Wang Y
Stem Cell Res; 2021 Aug; 55():102481. PubMed ID: 34419749
[TBL] [Abstract][Full Text] [Related]
16. Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9.
Yuan F; Guo D; Liu Y; Xu Y; Gao G; Wu Y; Yang F; Ke X; Lai K; Wei H; Li YX
Stem Cell Res; 2018 Jan; 26():67-71. PubMed ID: 29247816
[TBL] [Abstract][Full Text] [Related]
17. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.
Bara AM; Messana A; Herring A; Hazelbaker DZ; Eggan K; Barrett LE
Stem Cell Res; 2016 Sep; 17(2):441-443. PubMed ID: 27879221
[TBL] [Abstract][Full Text] [Related]
18. Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.
Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
Stem Cell Res; 2017 Mar; 19():46-48. PubMed ID: 28413005
[TBL] [Abstract][Full Text] [Related]
19. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-20.
Shetty DK; Inamdar MS
Stem Cell Res; 2016 Mar; 16(2):207-9. PubMed ID: 27345969
[TBL] [Abstract][Full Text] [Related]
20. Generation of an S100B homozygous knockout pluripotent stem cell line (WAe009-A-94) by the CRISPR/Cas9 system.
Zhang P; Wang H; Li S; Guo T; Zhang R; Zhou P; Ding S
Stem Cell Res; 2022 Oct; 64():102924. PubMed ID: 36182708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
